In a groundbreaking study set to reshape our understanding of chronic low back pain, researchers have uncovered a novel cellular mechanism that perpetuates nociplastic pain — a type of chronic pain not directly caused by tissue damage but arising from altered nervous system processing. This discovery, published in Nature Communications, highlights an amplification loop in the dorsal horn of the spinal cord mediated by DCC (Deleted in Colorectal Cancer) signaling, triggered by osteoclasts at the vertebral endplate.
Chronic low back pain remains one of the leading causes of disability worldwide, yet its underlying neurobiological mechanisms are poorly understood. The current study led by Pan, Shen, Abatan, and colleagues employed male mouse models to elucidate how osteoclasts—bone-resorbing cells at the spinal endplates—initiate a pathological cascade that sustains pain hypersensitivity without ongoing tissue injury.
The team identified that increased osteoclast activity at the vertebral endplates elevates the expression of the Netrin-1 receptor DCC within the dorsal horn neurons of the spinal cord. DCC is traditionally known for its role in neural development and axonal guidance, but here it forms a positive feedback loop that amplifies pain signaling. This amplification loop enhances nociceptive neuronal excitability, driving persistent pain perception even in the absence of new peripheral damage.
Mechanistically, osteoclast-derived signals enhance DCC expression and activation in excitatory dorsal horn neurons, which in turn augment synaptic transmission and facilitate central sensitization—key hallmarks of nociplastic pain. This feedback loop was shown to maintain a sustained state of dorsal horn hyperexcitability, generating chronic low back pain phenotypes in the mouse model.
Importantly, pharmacological or genetic disruption of DCC signaling within the dorsal horn effectively broke the amplification loop, reversing hypersensitivity and reducing nociplastic pain responses. These interventions offer promising avenues for targeting central pain processing mechanisms rather than the peripheral pain sources, representing a paradigm shift in chronic pain therapeutics.
The study also links osteoclast activity with central nervous system plasticity, bridging two previously disconnected fields: bone metabolism and neural pain circuitry. This cross-disciplinary insight suggests that aberrant osteoclast function at spinal sites not only contributes to structural degeneration but actively drives maladaptive pain signaling cascades.
Given the complexity and heterogeneity of chronic low back pain in patients, these findings open new paths for precision medicine. Identifying biomarkers of osteoclast activity or dorsal horn DCC dynamics could help stratify patients who might benefit from therapies aimed at interrupting this novel amplification loop.
This innovative research underscores the importance of central nervous system targets in chronic nociplastic pain and challenges the existing framework that centers on peripheral tissue damage as a sole driver. By dissecting the molecular dialogue between bone-resorbing cells and spinal neurons, the study sets the stage for next-generation treatments combating one of the most prevalent and debilitating conditions globally.
As investigations continue, it is hoped that therapeutic strategies derived from this mechanism might alleviate the suffering of millions, improving quality of life and reducing healthcare burdens associated with chronic low back pain.
Subject of Research: Mechanisms of chronic nociplastic low back pain involving dorsal horn DCC signaling and osteoclast activity.
Article Title: Dorsal horn DCC amplification loop induced by endplate osteoclasts generates chronic nociplastic low back pain in male mice.
Article References:
Pan, D., Shen, M., Abatan, E. et al. Dorsal horn DCC amplification loop induced by endplate osteoclasts generates chronic nociplastic low back pain in male mice. Nat Commun (2026). https://doi.org/10.1038/s41467-026-75423-9
Image Credits: AI Generated
